Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
NCI-2020-00752
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Adult (18-64)
Older adult (65+)
CCTG MA.39
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Adult (18-64)
Older adult (65+)
NCI-2022-09876
Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
Adult (18-64)
Older adult (65+)
NCI-2019-00179
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer
Adult (18-64)
Older adult (65+)
NCI-2021-06042
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative
Adult (18-64)
Older adult (65+)
NCI-2021-02851
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Adult (18-64)
Older adult (65+)
NCI-2020-03472
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Adult (18-64)
Older adult (65+)
S2209
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Child (birth - 17)
Adult (18-64)
Older adult (65+)
NCI-2019-08627
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
Adult (18-64)
Older adult (65+)
NRG-GY019
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Adult (18-64)
Older adult (65+)